I know there are a few good examples of different incubators where we are trying to get academia, government, and industry together. You mentioned bringing academia into the clinical setting. As we look towards getting this research into personalized medicine at the clinical setting, how would this be better for the health consumer? Do you have any idea of how much money we'd actually save the system? You'd be personalizing treatments for individuals and you wouldn't have all of these by-guess-and-by-golly treatments that sometimes end up making the patient worse.
On March 5th, 2013. See this statement in context.